Adjuvant corticosteroid therapy in 2 children with hepatosplenic candidiasis-related IRIS

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 10, 2009, Pages 794-796

  Saint Faust, Marie ^a   Boyer, Corinne ^b   Gari Toussaint, Martine ^c   Deville, Anne ^a   Poiree, Maryline ^a   Weintraub, Mickael ^d   Sirvent, Nicolas ^a  

^a Universitary Hospital LArchet2   (France)

^b Department of Pediatric Radiology ^*

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Children; Hepatosplenic candidiasis; Leukemia

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CANDIDA; CANDIDIASIS; CASE REPORT; CHILD; ECHOGRAPHY; FEMALE; HEPATITIS; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LABORATORY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADRENAL CORTEX HORMONES; CANDIDIASIS; CHEMOTHERAPY, ADJUVANT; CHILD; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LIVER DISEASES; MALE; REMISSION INDUCTION; SPLENIC DISEASES;

EID: 70349804760     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181b795ec     Document Type: Article

References (10)

1. Legrand F, Lecuit M, Dupont B, et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis. 2008;46:696-702.
2. Masood A, Sallah S. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leuk Res. 2005;29:493-501. Epub December 30, 2004.
3. Dupont B. Hepatosplenic candidiasis: A new immune reconstitution in.ammatory syndrome? J Med Mycol. 2007;17: 155-156.
4. Kirby A, Chapman C, Hassan I, et al. The diagnosis of hepatosplenic candidiasis by DNA analysis of tissue biopsy and serum. J Clin Pathol. 2004;57:764-765.
5. Ascioglu S, Rex JH, de Pauw B, et al. Invasive fungal infections cooperative group of the European organization for research and treatment of cancer; mycoses study group of the national institute of allergy and infectious diseases. De.ning opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis. 2002;34:7-14. Epub Novembr 26, 2001.
6. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (eortc/msg) consensus group. Clin Infect Dis. 2008;46:1813-1821.
7. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis. 2007; 7:395-401. (Pubitemid 46765196)
8. Murdoch DM, Venter WD, Van Rie A, et al. Immune reconstitution in.ammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther. 2007;4:9.
9. Stoll M, Schmidt RE. Adverse events of desirable gain in immunocompetence: the immune restoration in.ammatory syndromes. Autoimmun Rev. 2004;3:243-249.
10. Legrand F, Dupont B, Lecuit M, et al. Adjuvant corticosteroid therapy is bene.cial and safe during chronic disseminated candidiasis. 45th International Conference on Antimicrobial Agents and Chemotherapy, Washington, 2005:abstract m-971, p.424.